Hmn-174

Diabetes is a chronic metabolic disorder characterized by elevated blood glucose levels, leading to various complications affecting multiple organs, particularly the kidneys, eyes, nerves, and cardiovascular system. Effective management of diabetes is crucial to prevent these complications and improve patient outcomes. In recent years, researchers have been actively seeking novel biomarkers to improve early diagnosis, monitor disease progression, and evaluate treatment efficacy. HbA1c-174, also known as Hemoglobin A1c with allele 174, is an intriguing biomarker that has garnered significant interest in the scientific community. This article provides an in-depth overview of HbA1c-174, its association with diabetes, and its implications for future research and clinical practice.

Hemoglobin A1c (HbA1c) is a widely used biomarker to assess long-term blood glucose control in patients with diabetes. It represents the average serum glucose concentration over the past 2-3 months and is calculated from hemoglobin (Hb), a glycoprotein in red blood cells. The World Health Organization (WHO) and International Diabetes Federation (IDF) have established reference values for HbA1c to diagnose and manage diabetes. hmn-174